אודות פרק זה

אנגלית
ארצות הברית

תעתיק 🔗

חיפוש פרקים ישנים

חפש פרקים קודמים של Center for Advanced Studies (CAS) Research Focus CRISPR/Cas.

פרקים אחרים בפודקאסט הזה

Genome editing gives precise control of the type of genetic modification made to a cell. Hematopoietic stem cells have pharmacologic properties of durability and output that still remain untapped. Matthew Porteus and his group are using genome editing of hematopoietic stem cells to develop new cla‮…
Sickle cell disease is one of the most prevalent diseases worldwide. Even optimal conventional care has demonstrated inferiority compared to curative options such as hematopoietic stem cell transplantation. Gene editing promises an elegant alternative cure to all patients lacking a matched donor, ‮…
The evetn is part of the lecture series "Out of the Box: CRISPR/Cas". The lecture series reflects on the consequences of the revolutionary gene editing technology CRISPR/Cas in the fields of natural sciences and medicine, as well as its societal significance.
Panel discussion with Dr. Oana Dima, Prof. Dr. Caroline Gutjahr, and Prof. Dr. Kai P. Purnhagen | Moderation: Christoph von Eichhorn. The dicussion is the final event in the lecture series "Out of the Box: CRISPR/Cas". The lecture series reflects on the consequences of the revolutionary gene editi‮…
הצהרה: הפודקאסט והגרפיקה המוטבעים בדף זה הם מ-Center for Advanced Studies (CAS), שהוא רכושו של בעליו ואינו קשור או מאושר על ידי Listen Notes, Inc.